Rheonix Gets FDA Clearance of Automated Workstation, STI Detection Test
The FDA has granted Rheonix 510(k) clearance of its automated Encompass MDxWorkstation, along with its STI TriPlex Assay and male STI detection kit.
Read MorePosted by Andy Lundin | Jan 11, 2022 | Lab Automation |
The FDA has granted Rheonix 510(k) clearance of its automated Encompass MDxWorkstation, along with its STI TriPlex Assay and male STI detection kit.
Read MorePosted by Andy Lundin | Jan 11, 2022 | Covid 19 |
Researchers from Seattle published insights toward reforming actions made during the pandemic that hampered community testing of COVID-19 in the city.
Read MorePosted by Andy Lundin | Jan 11, 2022 | Covid 19, Immunoassay Reagents & test Kits |
According to experts who evaluated seven COVID-19 rapid tests, none were rated as excellent and some had notable usability concerns.
Read MorePosted by Andy Lundin | Jan 10, 2022 | Covid 19, Diagnostic Technologies |
Computational algorithms can also play a valuable role in identifying cases that traditional clinical diagnosis methods may miss.
Read MorePosted by Andy Lundin | Jan 10, 2022 | Company News, Microbiology Reagents & Test Kits |
BD received FDA 510(k) clearance for the BD Kiestra IdentifA system, which automates the preparation of bacterial identification testing.
Read More